posted on Jan, 17 2008 @ 09:19 PM
I'm not involved in anything, but I did read that UK-based Acambis has had successful clinical trials with their ACAM-FLU-A vaccine. The vaccine is
being developed to be a once-in-a-lifetime vaccine against type A influenza, as it acts on a different protein than conventional vaccinations, and
this new target protein doesn't appear to mutate. Furthermore, since all pandemic influenzas are of type A (including H5N1), it does have the
potential to be a vaccination against bird flu that could be stockpiled in advance of a pandemic.